Shukra Pharmaceuticals Reschedules 33rd AGM to September 28, 2026
Shukra Pharmaceuticals Limited has rescheduled its 33rd Annual General Meeting (AGM) to September 28, 2026. The book closure dates are revised to September 22-28, 2026. The meeting will be held via Video Conference/Other Audio-Visual Means.
Rescheduling of an AGM is a procedural change that typically has a low impact on the company's operations or stock price.
The announcement is a rescheduling of a corporate event and does not contain any positive or negative financial or business performance information.
Shukra Pharmaceuticals Limited has announced the rescheduling of its 33rd Annual General Meeting (AGM) due to unavoidable administrative exigencies.
The AGM, originally planned for September 22, 2026, will now be held on Monday, September 28, 2026, at 12:00 p.m. (IST). The meeting will be conducted through Video Conferencing (VC) and Other Audio-Visual Means (OAVM).
In conjunction with the revised AGM date, the company has also updated its book closure dates. The Register of Members and Share Transfer Books will be closed from Tuesday, September 22, 2026, to Monday, September 28, 2026, inclusive. The remote e-voting period and cut-off date will be adjusted accordingly and details will be provided in the final Notice of AGM.
All other matters and appointments approved in the previous board meeting on August 22, 2026, including the appointment of Mrs. Rupal Patel as Scrutinizer, remain unchanged.
A plain-language summary of a public exchange filing by Shukra Pharmaceuticals Limited. Read the original for the full detail.